Novadip Biosciences Stock

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

Sign up today and learn more about Novadip Biosciences Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Novadip Biosciences Stock

Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.

Funding History

September 2015$28.0M
October 2021$19.0M
November 2022$24.0M
November 2022$16.0M

Management

Board Member

Franssen Christina

Board Member

Jason Zhou

Chief Executive Officer and co-founder

Jean- François Pollet

Chief Medical Officer

Judy Ashworth

Chief Scientific Officer and co-founder

Denis Dufrane

Chief Executive Officer

Jeffrey D. Abbey

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo